Supplementary Figures S1-S5; Supplementary Tables S1-S4; and Supplementary Materials &amp; Methods from A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity